WO2024087158A1 - 含硅高抗刻蚀分子玻璃光刻胶化合物及其制备方法和应用 - Google Patents
含硅高抗刻蚀分子玻璃光刻胶化合物及其制备方法和应用 Download PDFInfo
- Publication number
- WO2024087158A1 WO2024087158A1 PCT/CN2022/128209 CN2022128209W WO2024087158A1 WO 2024087158 A1 WO2024087158 A1 WO 2024087158A1 CN 2022128209 W CN2022128209 W CN 2022128209W WO 2024087158 A1 WO2024087158 A1 WO 2024087158A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkoxy
- compound
- photoresist composition
- aryl
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 106
- 229920002120 photoresistant polymer Polymers 0.000 title claims abstract description 106
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 title abstract description 12
- 239000011521 glass Substances 0.000 title abstract description 12
- 229910052710 silicon Inorganic materials 0.000 title abstract description 12
- 239000010703 silicon Substances 0.000 title abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 16
- 238000001459 lithography Methods 0.000 claims abstract description 15
- 238000000609 electron-beam lithography Methods 0.000 claims abstract description 7
- 238000001900 extreme ultraviolet lithography Methods 0.000 claims abstract description 7
- 239000000758 substrate Substances 0.000 claims abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 80
- 239000000203 mixture Substances 0.000 claims description 64
- -1 oxacyclopropyl Chemical group 0.000 claims description 59
- 125000003118 aryl group Chemical group 0.000 claims description 28
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 18
- 125000000623 heterocyclic group Chemical group 0.000 claims description 14
- 238000000206 photolithography Methods 0.000 claims description 13
- 125000003860 C1-C20 alkoxy group Chemical group 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 239000003431 cross linking reagent Substances 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 6
- 125000006651 (C3-C20) cycloalkyl group Chemical group 0.000 claims description 5
- 125000003358 C2-C20 alkenyl group Chemical group 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 7
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 238000010894 electron beam technology Methods 0.000 abstract description 6
- 238000004528 spin coating Methods 0.000 abstract description 5
- 239000002244 precipitate Substances 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 238000003860 storage Methods 0.000 abstract description 2
- 238000001259 photo etching Methods 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 21
- 125000004432 carbon atom Chemical group C* 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 150000002430 hydrocarbons Chemical group 0.000 description 10
- 235000012431 wafers Nutrition 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 125000002619 bicyclic group Chemical group 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 238000009792 diffusion process Methods 0.000 description 7
- 239000003112 inhibitor Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 125000002950 monocyclic group Chemical group 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 238000005530 etching Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 125000001072 heteroaryl group Chemical group 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 125000003003 spiro group Chemical group 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 2
- 125000006714 (C3-C10) heterocyclyl group Chemical group 0.000 description 2
- 125000006708 (C5-C14) heteroaryl group Chemical group 0.000 description 2
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-bis(diphenylphosphino)propane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- YMEKEHSRPZAOGO-UHFFFAOYSA-N boron triiodide Chemical compound IB(I)I YMEKEHSRPZAOGO-UHFFFAOYSA-N 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 238000000276 deep-ultraviolet lithography Methods 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000006574 non-aromatic ring group Chemical group 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 125000003566 oxetanyl group Chemical group 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- MHYGQXWCZAYSLJ-UHFFFAOYSA-N tert-butyl-chloro-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](Cl)(C(C)(C)C)C1=CC=CC=C1 MHYGQXWCZAYSLJ-UHFFFAOYSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 2
- 238000000233 ultraviolet lithography Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- LWHOMMCIJIJIGV-UHFFFAOYSA-N (1,3-dioxobenzo[de]isoquinolin-2-yl) trifluoromethanesulfonate Chemical compound C1=CC(C(N(OS(=O)(=O)C(F)(F)F)C2=O)=O)=C3C2=CC=CC3=C1 LWHOMMCIJIJIGV-UHFFFAOYSA-N 0.000 description 1
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- XGQJGMGAMHFMAO-UHFFFAOYSA-N 1,3,4,6-tetrakis(methoxymethyl)-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione Chemical compound COCN1C(=O)N(COC)C2C1N(COC)C(=O)N2COC XGQJGMGAMHFMAO-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- QIJIUJYANDSEKG-UHFFFAOYSA-N 2,4,4-trimethylpentan-2-amine Chemical compound CC(C)(C)CC(C)(C)N QIJIUJYANDSEKG-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- SAILTPCYIYNOEL-UHFFFAOYSA-N 2-bromo-1,3,2-benzodioxaborole Chemical compound C1=CC=C2OB(Br)OC2=C1 SAILTPCYIYNOEL-UHFFFAOYSA-N 0.000 description 1
- JCVHIWLGFNCDAR-UHFFFAOYSA-N 2-bromo-3-methyloxirane Chemical compound CC1OC1Br JCVHIWLGFNCDAR-UHFFFAOYSA-N 0.000 description 1
- FAFGMAGIYHHRKN-UHFFFAOYSA-N 2-diphenylphosphanylethyl(diphenyl)phosphane;palladium Chemical compound [Pd].C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1.C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 FAFGMAGIYHHRKN-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- VEORPZCZECFIRK-UHFFFAOYSA-N 3,3',5,5'-tetrabromobisphenol A Chemical compound C=1C(Br)=C(O)C(Br)=CC=1C(C)(C)C1=CC(Br)=C(O)C(Br)=C1 VEORPZCZECFIRK-UHFFFAOYSA-N 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- HXFLZWAZSSPLCO-UHFFFAOYSA-N 6,6-dimethylbicyclo[3.1.1]heptyl Chemical group C1[C-]2C([CH2+])([CH2-])[C+]1CCC2 HXFLZWAZSSPLCO-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- YJLYANLCNIKXMG-UHFFFAOYSA-N N-Methyldioctylamine Chemical compound CCCCCCCCN(C)CCCCCCCC YJLYANLCNIKXMG-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- UEJFJTOGXLEPIV-UHFFFAOYSA-M bis(4-tert-butylphenyl)iodanium;4-methylbenzenesulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC(C(C)(C)C)=CC=C1[I+]C1=CC=C(C(C)(C)C)C=C1 UEJFJTOGXLEPIV-UHFFFAOYSA-M 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 125000005959 diazepanyl group Chemical group 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 125000005046 dihydronaphthyl group Chemical group 0.000 description 1
- LTYMSROWYAPPGB-UHFFFAOYSA-N diphenyl sulfide Chemical compound C=1C=CC=CC=1SC1=CC=CC=C1 LTYMSROWYAPPGB-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000005883 dithianyl group Chemical group 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- YNLFEVAOQLXINF-UHFFFAOYSA-N methylsulfanylmethane;tribromoborane Chemical compound CSC.BrB(Br)Br YNLFEVAOQLXINF-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- ZCYXXKJEDCHMGH-UHFFFAOYSA-N nonane Chemical compound CCCC[CH]CCCC ZCYXXKJEDCHMGH-UHFFFAOYSA-N 0.000 description 1
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- JGTNAGYHADQMCM-UHFFFAOYSA-N perfluorobutanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F JGTNAGYHADQMCM-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 238000001020 plasma etching Methods 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000001757 thermogravimetry curve Methods 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 1
- BPLUKJNHPBNVQL-UHFFFAOYSA-N triphenylarsine Chemical compound C1=CC=CC=C1[As](C=1C=CC=CC=1)C1=CC=CC=C1 BPLUKJNHPBNVQL-UHFFFAOYSA-N 0.000 description 1
- WLOQLWBIJZDHET-UHFFFAOYSA-N triphenylsulfonium Chemical compound C1=CC=CC=C1[S+](C=1C=CC=CC=1)C1=CC=CC=C1 WLOQLWBIJZDHET-UHFFFAOYSA-N 0.000 description 1
- 239000012953 triphenylsulfonium Substances 0.000 description 1
- FAYMLNNRGCYLSR-UHFFFAOYSA-M triphenylsulfonium triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F.C1=CC=CC=C1[S+](C=1C=CC=CC=1)C1=CC=CC=C1 FAYMLNNRGCYLSR-UHFFFAOYSA-M 0.000 description 1
- 125000005455 trithianyl group Chemical group 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/04—Esters of silicic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/04—Esters of silicic acids
- C07F7/06—Esters of silicic acids with hydroxyaryl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
- G03F7/075—Silicon-containing compounds
Definitions
- the invention belongs to the technical field of photolithography, and in particular relates to a silicon-containing highly etch-resistant molecular glass photoresist compound and a preparation method and application thereof.
- Molecular glass is a low molar mass material that does not crystallize on a time scale.
- Amorphous molecular glass materials can form uniform, transparent films with a glass transition process unique to polymers. In addition, they have high thermal stability and isotropy.
- molecular glass photoresists Compared with traditional polymer photoresists with molecular weight distribution, molecular glass photoresists have the advantages of monodispersity, small free volume, and no intermolecular chain entanglement.
- molecular glass photoresists and photoacid generators have roughly the same molecular size, and the two have good compatibility.
- the etching process is an important process that is essential to achieve high-resolution patterns.
- oxygen plasma is usually used to transfer the upper photoresist pattern to the lower layer. Therefore, the upper photoresist needs to have high oxygen plasma etching resistance. It is necessary to develop ultra-high resolution molecular glass photoresist with high etching resistance to optimize lithography performance.
- the purpose of the present invention is to provide a type of molecular glass photoresist with high etching resistance and a preparation method thereof.
- Another step of the present invention is to provide the application of the above-mentioned molecular glass photoresist with high etching resistance in extreme ultraviolet lithography, deep ultraviolet lithography, ultraviolet lithography and electron beam lithography.
- Each R b1 is the same or different, and is independently selected from C 1-20 alkyl, C 3-20 cycloalkyl, C 2-20 alkenyl, 3-20 membered heterocyclyl, and C 6-20 aryl.
- At least one of R 1 , R 2 and R 3 is not H, or at least one of them is not OH, or at least one of them is not C 1-20 alkyl.
- each R 1 , R 2 , and R 3 are the same or different and are independently selected from H, OH, C 1-8 alkoxy, C 1-8 alkoxy-C( ⁇ O)O—, C 1-8 alkoxy-C 1-8 alkoxy-, C 6-14 aryl-C( ⁇ O)OC 1-8 alkoxy-, C 1-8 alkoxy-C( ⁇ O)OC 1-8 alkoxy-C 1-8 alkoxy, C 6-14 aryl-C( ⁇ O)OC 1-8 alkoxy-C 1-8 alkoxy-, C 3-8 cycloalkyloxy-C( ⁇ O)O—, C 3-8 cycloalkyloxy-C( ⁇ O)-C 1-8 alkoxy-, C 2-8 alkenyl-C 1-8 alkoxy-, 3-8 membered heterocyclyl-O—, 3-8 membered heterocyclyl-C 1-8 alkoxy-;
- each R 1 , R 2 , R 3 is the same or different and is independently selected from H, OH, methoxy,
- each R 4 is the same or different and is independently selected from OH, methoxy,
- the heterocyclic group is an oxygen-containing heterocyclic group, for example, a 3-8-membered oxacycloalkyl group, such as oxacyclopropyl, oxetanyl, oxacyclopentyl and oxacyclohexyl.
- the compound represented by formula (I) has the following structure:
- the present invention also provides a method for preparing the compound represented by formula (I), comprising the following steps:
- R 1 , R 2 , R 3 , and R 4 are independently defined as above;
- R 41 are independently selected from OH, C 1-20 alkyl or C 1-20 alkoxy, wherein at least one R 41 is -OH;
- X is OH, Cl, Br or I;
- L is -B(OH) 2 , -B(OC 1-20 alkyl) 2 , wherein each Y 1 is the same or different and is independently selected from C 1-20 alkylene, each Y 2 is the same or different and is independently selected from H or C 1-20 alkyl;
- L is preferably -B(OH) 2 ,
- step (1) when the reactant is R 4 X, the reaction is carried out under the action of a base, such as at least one of imidazole, pyridine, sodium carbonate, potassium carbonate, cesium carbonate, triethylamine, and potassium hydroxide;
- a base such as at least one of imidazole, pyridine, sodium carbonate, potassium carbonate, cesium carbonate, triethylamine, and potassium hydroxide;
- the reaction temperature is, for example, room temperature
- the reaction solvent is, for example, at least one of tetrahydrofuran, N-methylpyrrolidone, and acetonitrile;
- step (1) when the reactant is (R 4 ) 2 NH, the reaction is carried out under the action of an acid, such as concentrated H 2 SO 4 , and the reaction temperature is, for example, 80-120°C.
- an acid such as concentrated H 2 SO 4
- the reaction in step (2), can be carried out under the action of a palladium-containing catalyst, such as tetrakis(triphenylphosphine)palladium(0), [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium, tetrakis(triphenylarsine)palladium(0), tetrakis(tri-tert-butylphosphine)palladium(0), tetrakis(trimethoxyphosphine)palladium(0), bis(1,2-bis(diphenylphosphino)ethane)palladium(0), and bis(1,3-bis(diphenylphosphino)propane)palladium(0);
- a base such as at least one of sodium carbonate, cesium carbonate, potassium acetate, potassium phosphate, tetrabutylammonium fluoride, ces
- R 1 , R 2 , and R 3 in the compound represented by formula (I) may further participate in the reaction to obtain a compound represented by formula (I) in which R 1 , R 2 , and R 3 are other groups except OH or C 1-20 alkoxy;
- the preparation method further comprises the following step (3): when OH exists in R 1 , R 2 , and R 3 of the compound of formula (I), the OH may further react with R 1 'X 1 , R 2 'X 2 and/or R 3 'X 3 to obtain other compounds of formula (I) in which R 1 , R 2 , and R 3 are other than OH;
- the preparation method further comprises the following step (4): when there is a C 1-20 alkoxy group in R 1 , R 2 , and R 3 of the compound of formula (I), the C 1-20 alkoxy group can be further reacted to obtain OH, and the OH can be further reacted in step (3) to obtain other compounds of formula (I) in which R 1 , R 2 , and R 3 are other than a C 1-20 alkoxy group;
- R 1 ', R 2 ', R 3 ' are groups formed by R 1 , R 2 , R 3 losing one oxygen at the connection point with the parent core, that is, R 1 '-O-, R 2 '-O-, R 3 '-O- represent R 1 , R 2 , R 3 respectively;
- X 1 , X 2 , X 3 are the same or different and are independently selected from OH, Cl, Br, I.
- the reaction in step (3), is preferably carried out in the presence of a catalyst, such as at least one of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), potassium carbonate, 4-dimethylaminopyridine (DMAP) or sodium hydride;
- a catalyst such as at least one of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), potassium carbonate, 4-dimethylaminopyridine (DMAP) or sodium hydride
- the reaction temperature is, for example, room temperature
- the reaction time is, for example, 2-12 hours
- the reaction can be carried out in the presence of a solvent, such as at least one of tetrahydrofuran or acetone.
- step (3) when the molar ratio of the compound of formula (I) as a raw material to the total amount of R 1 'X 1 , R 2 'X 2 and/or R 3 'X 3 is 1:1-1.2, a compound of formula (I) with fully protected hydroxyl groups can be obtained; when the molar ratio of the compound of formula (I) as a raw material to R 1 'X 1 , R 2 'X 2 and/or R 3 'X 3 is 1:0.2-0.8, a compound of formula (I) with partially protected hydroxyl groups can be obtained.
- R 1 , R 2 , and R 3 in the compound of formula (I) as a raw material can generate OH under the action of a Lewis acid
- the Lewis acid is, for example, at least one of boron tribromide, boron triiodide, N,N-diethylaniline complexed boron triiodide, boron tribromide-dimethyl sulfide, 9-bromo-9-borabicyclo[3.3.0]nonane, and catechol boron bromide (catalyzed by boron trifluoride ether).
- the solvent of the reaction is, for example, dichloromethane or 1,2-dichloroethane.
- the present invention also provides the use of the compound represented by formula (I) in photolithography, such as use in photoresist.
- the present invention also provides a photoresist composition, comprising the compound of formula (I).
- the photoresist composition may be a positive photoresist composition or a negative photoresist composition.
- the compound of formula (I) wherein at most one of R 1 , R 2 , R 3 and R 4 is OH is
- the positive photoresist composition a is composed of the compound (I-a), a photoresist solvent, and a photoacid generator, that is, the positive photoresist composition a is a positive single-molecule photoresist.
- the positive photoresist composition a contains, by mass fraction, 0.1% to 10% of the compound (I-a) and 0.01% to 1% of a photoacid generator.
- the positive photoresist composition a may further selectively contain other photoresists, acid diffusion inhibitors, and the like.
- the positive photoresist composition a contains, by mass fraction, 0% to 5% of other photoresists and 0% to 0.1% of an acid diffusion inhibitor.
- the photoresist composition is a negative photoresist composition b, comprising compound (Ib), wherein compound (Ib) is a compound of formula (I) wherein R 1 , R 2 , R 3 , and R 4 contain at least two -OH groups.
- the negative photoresist composition b is composed of the compound (I-b), a photoresist solvent, a photoacid generator, and a crosslinking agent, that is, the negative photoresist composition b is a negative single-molecule photoresist.
- the negative photoresist composition b contains, by mass fraction, 0.1% to 10% of the compound (I-b), 0.01% to 1% of a photoacid generator, and 0.01% to 5% of a crosslinking agent.
- the negative photoresist composition b may further selectively contain other photoresists, acid diffusion inhibitors, and the like.
- the negative photoresist composition b contains 0% to 5% of other photoresists and 0% to 0.1% of an acid diffusion inhibitor.
- the photoresist composition is a negative photoresist composition c, comprising compound (Ic), wherein the compound (Ic) is a compound of formula (I) wherein in the compound represented by formula (I), at least one of R 1 , R 2 , R 3 , and R 4 is a C 2-20 alkenyl-C 1-20 alkoxy group, a 3-8 membered heterocyclyl-O-, or a 3-8 membered heterocyclyl-C 1-8 alkoxy group.
- the negative photoresist composition c is composed of the compound (I-c), a photoresist solvent, and a photoacid generator, that is, the negative photoresist composition c is another negative single-molecule photoresist.
- the negative photoresist composition c contains, by mass fraction, 0.1% to 10% of the compound (I-c) and 0.01% to 1% of a photoacid generator.
- the negative photoresist composition c may further selectively contain a photoresist, an acid diffusion inhibitor, a cross-linking agent, and the like.
- the negative photoresist composition c contains, by mass fraction, 0% to 5% of photoresist, 0% to 0.1% of acid diffusion inhibitor, and 0.01% to 5% of cross-linking agent.
- the other photoresist may be a photoresist known in the prior art, such as the photoresists disclosed in patent documents 201210156675.6, 201210070713.6, 201611105094.4, 201911329042.9, 201911167289.5, and 202010803879.9.
- the photoacid generator may be ionic or non-ionic, such as at least one selected from triphenylsulfonium trifluoromethanesulfonate, triphenylsulfonium perfluorobutylsulfonate, di(4-tert-butylphenyl)iodonium p-toluenesulfonate, N-hydroxynaphthalimide trifluoromethanesulfonate, 2-phenyl-(4-phenylsulfide)phenylsulfide hexafluoroantimonate, benzyl(4-hydroxyphenyl)methylsulfonium hexafluoroantimonate, hexafluoroantimonate mixed salt, and the like.
- the photoresist solvent may be selected from at least one of propylene glycol methyl ether acetate (PGMEA), ethyl lactate, ethylene glycol monomethyl ether, cyclohexanone, and the like.
- PGMEA propylene glycol methyl ether acetate
- ethyl lactate ethylene glycol monomethyl ether
- cyclohexanone cyclohexanone
- the acid diffusion inhibitor may be selected from n-octylamine, tri-n-octylamine, N-methyldi-n-octylamine, tert-octylamine and the like.
- the cross-linking agent may be at least one selected from tetramethoxymethyl glycoluril, bisphenol A type glycidyl ether and the like.
- the photoresist composition may further include other additives, such as a sensitizer, a surfactant, a dye, a stabilizer, a cosolvent, and the like.
- additives such as a sensitizer, a surfactant, a dye, a stabilizer, a cosolvent, and the like.
- the present invention further provides an application of the compound represented by formula (I) or the photoresist composition in lithography processes such as 365nm lithography, 248nm lithography, 193nm lithography, extreme ultraviolet (EUV) lithography or electron beam lithography (EBL).
- lithography processes such as 365nm lithography, 248nm lithography, 193nm lithography, extreme ultraviolet (EUV) lithography or electron beam lithography (EBL).
- the present invention also provides a photoresist coating, comprising the compound shown in formula (I).
- the present invention also provides a method for preparing the photoresist coating, which comprises applying (such as spin coating) the photoresist composition on a substrate.
- the coating method is to perform spin coating on the substrate by a coating machine.
- the substrate may be a silicon wafer, a silicon dioxide wafer, or a compound semiconductor wafer.
- the silicon wafer is preferably a silicon wafer that has been hydrophobically treated.
- the present invention introduces silicon-containing groups into the photoresist main material molecules to obtain a photoresist material with high etching resistance.
- the compound represented by the general formula (I) of the present invention is a stereo-asymmetric amorphous small molecule compound with a simple molecular structure, controllable molecular weight, simple synthesis steps, high thermal stability, no precipitation during baking, not easy to denature during photolithography, high melting point and glass transition temperature (melting points are all above 100°C), able to meet the requirements of photolithography technology, and no change in the film structure during high-temperature baking.
- the photoresist composition of the present invention can be prepared into a uniform film, which has good resolution, photosensitivity, adhesion, is easy to store, and in the film-making process, the molecular glass as a matrix component does not precipitate.
- the negative photoresist composition prepared by the present invention has good film-forming properties, high thermal stability, is not easy to denature during storage, and has low viscosity, and does not need to be additionally diluted with solvent during use. After electron beam exposure and development, the exposure pattern has high contrast, excellent resolution, good sensitivity, and can reach a photolithography line width of 25-30nm.
- FIG1 is a TGA curve of compound (IB). When the temperature is 300° C., the decomposition content is less than 10%. It can be seen that compound (1A) has high thermal stability.
- FIG. 2 is a SEM result of electron beam exposure of compound (IB) with 60 nm periodic dense lines.
- FIG. 3 is a SEM result of 60 nm periodic lines of the electron beam exposure of compound (IB-2).
- the numerical ranges recorded in this specification and claims are equivalent to recording at least each specific integer value therein.
- the numerical range “1-20” is equivalent to recording each integer value in the numerical range “1-20", namely 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 161, 7, 18, 19, 20.
- C 1-20 alkyl is understood to mean straight-chain and branched alkyl groups having 1 to 20 carbon atoms, preferably “C 1-8 alkyl groups”.
- C 1-8 alkyl groups means straight-chain and branched alkyl groups having 1, 2, 3, 4, 5, 6, 7, or 8 carbon atoms
- C 1-6 alkyl groups means straight-chain and branched alkyl groups having 1, 2, 3, 4, 5, or 6 carbon atoms.
- the alkyl group is, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, 2-methylbutyl, 1-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, neopentyl, 1,1-dimethylpropyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 2-ethylbutyl, 1-ethylbutyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, 1,1-dimethylbutyl, 2,3-dimethylbutyl, 1,3-dimethylbutyl or 1,2-dimethylbutyl, or the like or isomers thereof.
- C 3-20 cycloalkyl is understood to mean a saturated monovalent monocyclic, bicyclic (such as condensed, bridged, spiro) hydrocarbon ring or tricyclic alkane having 3 to 29 carbon atoms, preferably a "C 3-12 cycloalkyl", more preferably a "C 3-8 cycloalkyl".
- C 3-12 cycloalkyl is understood to mean a saturated monovalent monocyclic, bicyclic (such as bridged, spiro) hydrocarbon ring or tricyclic alkane having 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms.
- the C 3-12 cycloalkyl group may be a monocyclic hydrocarbon group, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl or cyclodecyl, or a bicyclic hydrocarbon group, such as borneol, indolyl, hexahydroindolyl, tetrahydronaphthyl, decahydronaphthyl, bicyclo[2.1.1]hexyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.1]heptenyl, 6,6-dimethylbicyclo[3.1.1]heptyl, 2,6,6-trimethylbicyclo[3.1.1]heptyl, bicyclo[2.2.2]octyl, 2,7-diazaspiro[3,5]nonanyl, 2,6-diaza
- C 2-20 alkenyl is understood to mean a straight or branched monovalent hydrocarbon group containing one or more double bonds and having 2 to 20 carbon atoms, preferably a "C 2-10 alkenyl".
- C 2-10 alkenyl is understood to preferably mean a straight or branched monovalent hydrocarbon group containing one or more double bonds and having 2, 3, 4, 5, 6, 7, 8, 9 or 10 carbon atoms, more preferably a "C 2-8 alkenyl”.
- C 2-10 alkenyl is understood to preferably mean a straight or branched monovalent hydrocarbon group containing one or more double bonds and having 2, 3, 4, 5, 6, 7 or 8 carbon atoms, for example, having 2, 3, 4, 5 or 6 carbon atoms (i.e., C 2-6 alkenyl), having 2 or 3 carbon atoms (i.e., C 2-3 alkenyl). It is understood that in case the alkenyl contains more than one double bond, the double bonds may be separated from each other or conjugated.
- the alkenyl group is, for example, vinyl, allyl, (E)-2-methylvinyl, (Z)-2-methylvinyl, (E)-but-2-enyl, (Z)-but-2-enyl, (E)-but-1-enyl, (Z)-but-1-enyl, pent-4-enyl, (E)-pent-3-enyl, (Z)-pent-3-enyl, (E)-pent-2-enyl, (Z)-pent-2-enyl, (E)- Pent-1-enyl, (Z)-pent-1-enyl, hex-5-enyl, (E)-hex-4-enyl, (Z)-hex-4-enyl, (E)-hex-3-enyl, (Z)-hex-3-enyl, (E)-hex-2-enyl, (Z)-hex-2-enyl, (E)-hex-1-enyl,
- 3-20 membered heterocyclyl refers to a saturated or unsaturated non-aromatic ring or ring system, for example, it is a 4-, 5-, 6- or 7-membered monocyclic ring, a 7-, 8-, 9-, 10-, 11- or 12-membered bicyclic ring (such as a fused ring, a bridged ring, a spirocyclic ring) or a 10-, 11-, 12-, 13-, 14- or 15-membered tricyclic ring system, and contains at least one, for example 1, 2, 3, 4, 5 or more heteroatoms selected from O, S and N, wherein N and S may also be optionally oxidized to various oxidation states to form nitrogen oxides, -S(O)- or -S(O) 2 -.
- the heterocyclyl may be selected from "3-10 membered heterocyclyl".
- the term "3-10 membered heterocyclyl” means a saturated or unsaturated non-aromatic ring or ring system, and contains at least one heteroatom selected from O, S and N.
- the heterocyclic group can be connected to the rest of the molecule by any one of the carbon atoms or the nitrogen atom (if present).
- the heterocyclic group can include fused or bridged rings and spirocyclic rings.
- the heterocyclic group can include but is not limited to: 4-membered rings, such as azetidinyl, oxetanyl; 5-membered rings, such as tetrahydrofuranyl, dioxolyl, pyrrolidinyl, imidazolidinyl, pyrazolidinyl, pyrrolinyl; or 6-membered rings, such as tetrahydropyranyl, piperidinyl, morpholinyl, dithianyl, thiomorpholinyl, piperazinyl or trithianyl; or 7-membered rings, such as diazepanyl.
- 4-membered rings such as azetidinyl, oxetanyl
- 5-membered rings such as tetrahydrofuranyl, dioxolyl, pyrrolidinyl, imidazolidinyl, pyrazolidinyl, pyrrolinyl
- 6-membered rings
- C 6-20 aryl should be understood to preferably mean a monovalent aromatic or partially aromatic monocyclic, bicyclic (such as fused, bridged, spiro) or tricyclic hydrocarbon ring having 6 to 20 carbon atoms, which may be a single aromatic ring or a polyaromatic ring fused together, preferably a "C 6-14 aryl”.
- C 6-14 aryl is to be understood as preferably meaning a monovalent aromatic or partially aromatic monocyclic, bicyclic or tricyclic hydrocarbon ring (“C 6-14 aryl") having 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms, in particular a ring having 6 carbon atoms (“C 6 aryl”), such as phenyl or biphenyl, or a ring having 9 carbon atoms (“C 9 aryl”), such as indanyl or indenyl, or a ring having 10 carbon atoms (“C 10 aryl”), such as tetrahydronaphthyl, dihydronaphthyl or naphthyl, or a ring having 13 carbon atoms (“C 13 aryl”), such as fluorenyl, or a ring having 14 carbon atoms (“C 14 aryl”), such as anthracenyl.
- C 6-20 aryl When the C 6-20 aryl is substituted, it may be mono-
- 5-20 membered heteroaryl is understood to include monovalent monocyclic, bicyclic (e.g. fused, bridged, spiro) or tricyclic aromatic ring systems having 5 to 20 ring atoms and containing 1 to 5 heteroatoms independently selected from N, O and S, for example "5-14 membered heteroaryl".
- the term "5-14 membered heteroaryl” is understood to include monovalent monocyclic, bicyclic or tricyclic aromatic ring systems having 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 ring atoms, in particular 5 or 6 or 9 or 10 carbon atoms, and containing 1 to 5, preferably 1 to 3 heteroatoms each independently selected from N, O and S and, in each case, additionally, may be benzo-fused.
- Heteroaryl also refers to a radical in which a heteroaromatic ring is fused to one or more aryl, alicyclic or heterocyclyl rings, wherein the radical or point of attachment is on the heteroaromatic ring.
- Example 5 Synthesis of Compound (IB-2) Referring to Example 1-4, the tert-butyldiphenylsilyl group was replaced with tert-butyldimethylsilyl group to prepare Compound (IB-2) with the following molecular formula: MALDI-TOF (C 83 H 84 NaO 10 Si 2 ) m/z: 1048.497.
- Example 7 Preparation of a negative photoresist composition containing compound (IB-2)
- Example 6 Compound (IB-2) was replaced by Compound (IB) to prepare a 30 mg/mL negative photoresist composition.
- Example 8 Lithographic performance of negative photoresist composition containing compound (IB)
- Example 6 An untreated blank silicon wafer was selected, and the dust on the surface was blown off by a nitrogen gun.
- the negative photoresist composition prepared in Example 6 was spin-coated on the silicon wafer, and the spin-coating parameters were set to 2800rpm/90s, and the pre-baking parameters were 80°C/180s.
- the thickness of the film was measured by an optical ellipsometer, which was 43nm.
- An electron beam with an accelerating voltage of 100kV was used for exposure, and the post-baking parameters were 90°C/120s.
- the photoresist composition can achieve 30nm photolithography stripes, and has a high sensitivity (166 ⁇ C/ cm2 ) and a high contrast.
- Example 9 Lithographic performance of negative photoresist composition containing compound (IB-2)
- Example 7 An untreated blank silicon wafer was selected, and the dust on the surface was blown off by a nitrogen gun.
- the negative photoresist composition prepared in Example 7 was spin-coated on the silicon wafer, and the spin-coating parameters were set to 4500rpm/90s, and the pre-baking parameters were 80°C/180s.
- the film thickness was measured by an optical ellipsometer and was 41.2nm.
- An electron beam with an accelerating voltage of 100kV was used for exposure, and the post-baking parameters were 90°C/120s. Developed with methyl isobutyl ketone developer for 60s and rinsed with isopropanol for 60s.
- the photoresist composition can achieve 30nm photolithography stripes, and has a higher sensitivity (320 ⁇ C/ cm2 ) and a higher contrast.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明属于光刻技术领域,具体涉及一种含硅高抗刻蚀分子玻璃光刻胶化合物及其的制备方法和及应用。本发明所提供的化合物分子结构简洁,分子量可控,合成步骤简单,且其具有较高的热稳定性,烘烤中不析出,光刻中不易变性;所提供的负性分子玻璃光刻胶具有较好的成膜性,较高的热稳定性,储存不易变性,且粘度低,使用过程中无需额外使用溶剂稀释。该化合物制备的光刻胶在基片上通过旋涂法可以得到均匀的薄膜,其配方可用于365nm光刻、248光刻、193nm光刻、极紫外光刻及电子束光刻等现代光刻技术中。通过电子束曝光显影,曝光图形具有较高的对比度,优异的分辨率,及较好的灵敏度。
Description
本发明属于光刻技术领域,具体涉及一种含硅高抗刻蚀分子玻璃光刻胶化合物及其的制备方法和及应用。
二十世纪五十年代后期,科学家发明了锗集成电路与硅集成电路,集成电路的出现推动了半导体技术的快速发展。现代电子器件要求集成电路(芯片)的尺寸越来越小,集成度越来越高。集成电路的最小特征尺寸从微米级别、亚微米级别进入到纳米级别。
1798年Senefelder首次发明平板印刷技术,揭开了光刻技术发展的序幕,直到20世纪30年代左右,贝尔实验室首次用这种方式在晶圆上印刷电路。随后,美国陆军金刚石弹药引信实验室首次申请了光刻技术的专利并将其应用。1961年,这项技术正式走向商业化。随着光刻技术的逐渐发展,其经历了从紫外光刻(436nm,365nm)到深紫外光刻(248nm、193nm)再到更小尺寸的电子束光刻和极紫外光刻。目前极紫外光刻(EUVL)能够得到最小特征尺寸低于7nm的图案。在开发更快和更小的半导体器件的过程中,新型的光刻胶材料和光刻工艺目前正在由工业界和学术界进行联合探索研究。
分子玻璃是低摩尔质量材料,在时间尺度上不结晶。非晶态的分子玻璃材料可形成均匀、透明的薄膜,具有聚合物所特有的玻璃化转变过程。此外,它们具有很高的热稳定性和各向同性。与具有分子量分布的传统聚合物光刻胶相比,分子玻璃光刻胶具有单分散、较小的自由体积且不存在分子间链缠结的优势,而且分子玻璃光刻胶与光致产酸剂分子尺寸大致相同,两者具有较好地相容性。
蚀刻工艺是实现高分辨率图案必不可少的重要过程,在工艺中,通常使用氧等离子体将上层光刻胶图案转移至下层。因此,上层光刻胶需要高的氧等离子体抗刻蚀性。需要开发具备高抗刻蚀性的超高分辨率分子玻璃光刻胶,优化光刻性能。
发明内容
本发明的目的在于提供一类高抗刻蚀性分子玻璃光刻胶及其制备方法。
本发明的另一步地在于提供上述高抗刻蚀性分子玻璃光刻胶在极紫外光刻、深紫外光刻、紫外光刻和电子束光刻中的应用。
为改善上述技术问题,本发明提供一类式(I)所示的化合物:
其中,每个R
1、R
2、R
3相同或不同,彼此独立的选自H、OH、无取代或任选被一个、两个或更多个R
a取代的下列基团:C
1-20烷基、C
1-20烷氧基、C
1-20烷氧基-C(=O)O-、C
1-20烷氧基-C
1-20烷氧基-、C
6-20芳基-C(=O)O-C
1-20烷氧基-、C
1-20烷氧基-C(=O)O-C
1-20烷氧基-C
1-20烷氧基、C
6-20芳基-C(=O)O-C
1-20烷氧基-C
1-20烷氧基-、C
3-20环烷基氧基-C(=O)O-、C
3-20环烷基氧基-C(=O)-C
1-20烷氧基-、C
2-20烯基-C
1-20烷氧基-、3-20元杂环基-O-、3-20元杂环基-C
1-20烷氧基-;且R
1、R
2、R
3不同时选自H、OH或C
1-20烷基中的同一基团;
每个R
4相同或不同,彼此独立的选自OH、无取代或任选被一个、两个或更多个R
b取代的下列基团:C
1-20烷基、C
1-20烷氧基、C
1-20烷氧基-C(=O)O-、C
1-20烷氧基-C
1-20烷氧基-、C
6-20芳基-C(=O)O-C
1-20烷氧基-、C
1-20烷氧基-C(=O)O-C
1-20烷氧 基-C
1-20烷氧基-、C
6-20芳基-C(=O)O-C
1-20烷氧基-C
1-20烷氧基-、C
3-20环烷基氧基-C(=O)O-、C
3-20环烷基氧基-C(=O)-C
1-20烷氧基-、C
2-20烯基-C
1-20烷氧基-、3-20元杂环基-O-、3-20元杂环基-C
1-20烷氧基-、-OSi(R
b1)
3;且R
4中至少有一个为-OSi(R
b1)
3;
每个R
a、R
b相同或不同,彼此独立地选自氧代(=O)、C
1-20烷基、C
1-20烷氧基、C
3-20环烷基、C
2-20烯基、3-20元杂环基、C
6-20芳基;
每个R
b1相同或不同,彼此独立地选自C
1-20烷基、C
3-20环烷基、C
2-20烯基、3-20元杂环基、C
6-20芳基。
根据本发明的实施方案,在R
1、R
2、R
3中至少有一个基团不为H,或者至少有一个基团不为OH,或者至少有一个基团不为C
1-20烷基。
根据本发明的实施方案,每个R
1、R
2、R
3相同或不同,彼此独立的选自H、OH、C
1-10烷基、C
1-10烷氧基、C
1-10烷氧基-C(=O)O-、C
1-10烷氧基-C
1-10烷氧基-、C
6-20芳基-C(=O)O-C
1-10烷氧基-、C
1-10烷氧基-C(=O)O-C
1-10烷氧基-C
1-10烷氧基、C
6-20芳基-C(=O)O-C
1-10烷氧基-C
1-10烷氧基-、C
3-12环烷基氧基-C(=O)O-、C
3-12环烷基氧基-C(=O)-C
1-10烷氧基-、C
2-20烯基-C
1-10烷氧基-、3-12元杂环基-O-、3-12元杂环基-C
1-10烷氧基-;
根据本发明的实施方案,每个R
1、R
2、R
3相同或不同,彼此独立的选自H、OH、C
1-8烷氧基、C
1-8烷氧基-C(=O)O-、C
1-8烷氧基-C
1-8烷氧基-、C
6-14芳基-C(=O)O-C
1-8烷氧基-、C
1-8烷氧基-C(=O)O-C
1-8烷氧基-C
1-8烷氧基、C
6-14芳基-C(=O)O-C
1-8烷氧基-C
1-8烷氧基-、C
3-8环烷基氧基-C(=O)O-、C
3-8环烷基氧基-C(=O)-C
1-8烷氧基-、C
2-8烯基-C
1-8烷氧基-、3-8元杂环基-O-、3-8元杂环基-C
1-8烷氧基-;
*处为连接位点。
根据本发明的实施方案,每个R
4相同或不同,彼此独立地选自OH、C
1-20烷基、C
1-20烷氧基、(C
1-20烷基)
3SiO-、(芳基)
2(C
1-20烷基)SiO-、(芳基)(C
1-20烷基)
2SiO-、C
1-20烷氧基-C(=O)O-、C
1-20烷氧基-C
1-20烷氧基、C
6-20芳基-C(=O)O-C
1-20烷氧基、C
1-20烷氧基-C(=O)O-C
1-20烷氧基-C
1-20烷氧基、C
6-20芳基-C(=O)O-C
1-20烷氧基-C
1-20烷氧基、C
3-20环烷基氧基-C(=O)O-、C
3-20环烷基氧基-C(=O)-C
1-20烷氧基、C
2-20烯基-C
1-20烷氧基、3-20元杂环基-O-、3-20元杂环基-C
1-20烷氧基;且R
4中至少有一个为(C
1-20烷基)
3SiO-、(芳基)
2(C
1-20烷基)SiO-、(芳基)(C
1-20烷基)
2SiO-;
根据本发明的实施方案,每个R
4相同或不同,彼此独立地选自OH、C
1-8烷氧基、C
1-8烷氧基-C(=O)O-、C
1-8烷氧基-C
1-8烷氧基、C
6-14芳基-C(=O)O-C
1-8烷氧基、C
1-8烷氧基-C(=O)O-C
1-8烷氧基-C
1-8烷氧基、C
3-8环烷基氧基-C(=O)O-、C
3-8环烷基氧基-C(=O)-C
1-8烷氧基、C
2-8烯基-C
1-8烷氧基、3-8元杂环基-O-、3-8元杂环基-C
1-8烷氧基;
根据本发明的实施方案,每个R
4相同或不同,彼此独立地选自OH、甲氧基、
在本发明的一个实施方式中,R
1、R
2、R
3、R
4中,所述杂环基为含氧杂环基,例如为3-8元氧杂环烷基,例如氧杂环丙基、氧杂环丁基、氧杂环戊基、氧杂环己基。
根据本发明的实施方案,式(I)所示化合物具有以下结构:
本发明还提供式(I)所示化合物的制备方法,包括以下步骤:
(1)化合物(II)与化合物R
4X或(R
4)
2NH反应得到化合物(III);
(2)化合物(III)与化合物(IV)反应生成式(I)所示化合物;
其中,R
1、R
2、R
3、R
4彼此独立地具有上文所述的定义;R
41彼此独立地选自OH、C
1-20烷基或C
1-20烷氧基,其中至少有一个R
41为-OH;X为OH、Cl、Br或I;L为-B(OH)
2、-B(OC
1-20烷基)
2、
其中每个Y
1相同或不同,彼此独立地选自C
1-20亚烷基,每个Y
2相同或不同,彼此独立地选自H或C
1-20烷基;L优选为-B(OH)
2、
根据本发明的实施方案,步骤(1)中,当反应物为R
4X时,所述反应在碱作用下进行,所述碱例如为咪唑、吡啶、碳酸钠、碳酸钾、碳酸铯、三乙胺、氢氧化钾中的至少一种;所述反应的温度例如为室温,所述反应的溶剂例如四氢呋喃、N-甲基吡咯烷酮、乙腈中的至少一种;
根据本发明的实施方案,步骤(1)中,当反应物为(R
4)
2NH时,所述反应在酸作用下进行,所述酸例如为浓H
2SO
4,所述反应的温度例如为80~120℃。
根据本发明的实施方案,步骤(2)中,所述反应可以在含钯催化剂的作用下进行,所述催化剂例如为四(三苯基膦)钯(0)、[1,1'-双(二苯基膦)二茂铁]二氯化钯、四(三苯基胂)钯(0)、四(三叔丁基膦)钯(0)、四(三甲氧基膦)钯(0)、双(1,2-双(二苯基膦)乙烷)钯(0)、双(1,3-双(二苯基膦)丙烷)钯(0)中的至少一种;所述反应优选在碱作用下进行,所述碱例如为碳酸钠、碳酸铯、醋酸钾、磷酸钾、氟化四丁基铵、氟化铯或氟化钾中的至少一种;所述反应的溶剂例如为丙酮、甲苯、二氧六环、四氢呋喃、苯甲醚中的至少一种;所述反应的温度可以为60℃~150℃,例如80℃~120℃。
根据本发明的实施方案,当R
1、R
2、R
3选自OH或C
1-20烷氧基时,式(I)所示化合物中的R
1、R
2、R
3还可以进一步参与反应,得到R
1、R
2、R
3为除OH或C
1-20烷氧基以外的其他基团的式(I)化合物;
根据本发明的实施方案,所述制备方法还包括以下步骤(3):当式(I)化合物的R
1、R
2、R
3中存在OH时,该OH可以进一步与R
1’X
1、R
2’X
2和/或R
3’X
3反应得到R
1、R
2、R
3为除OH以外的其他式(I)化合物;
根据本发明的实施方案,所述制备方法还包括以下步骤(4):当式(I)化合物的R
1、R
2、R
3中存在C
1-20烷氧基时,该C
1-20烷氧基可以进一步反应得到OH,该OH可以进一步通过步骤(3)的反应得到R
1、R
2、R
3为除C
1-20烷氧基以外的其他式(I)化合物;
其中,R
1’、R
2’、R
3’分别为R
1、R
2、R
3失去与母核连接处的一个氧所形成的基团,即R
1’-O-、R
2’-O-、R
3’-O-分别表示R
1、R
2、R
3;X
1、X
2、X
3相同或不同,彼此独立地选自OH、Cl、Br、I。
根据本发明的实施方案,步骤(3)中,所述反应优选在催化剂存在下进行,所述催化剂例如为1,8-二氮杂双环[5.4.0]十一碳-7-烯(DBU)、碳酸钾、4-二甲氨基吡啶(DMAP)或氢化钠中的至少一种;所述反应的温度例如为室温;所述反应的时间例如为2-12h;所述反应可以在溶剂存在下进行,所述反应的溶剂例如 为四氢呋喃或丙酮中的至少一种。
根据本发明的实施方案,在步骤(3)中,当作为原料的所述式(I)化合物与R
1’X
1、R
2’X
2和/或R
3’X
3总量的摩尔比为1:1~1.2时,可以得到羟基全保护的式(I)化合物;当作为原料的所述式(I)化合物与R
1’X
1、R
2’X
2和/或R
3’X
3的投料摩尔比为1:0.2~0.8时,可以得到羟基部分保护的式(I)化合物。
根据本发明的实施方案,步骤(4)中,作为原料的所述式(I)化合物中的R
1、R
2、R
3可以在Lewis酸的作用下生成OH,所述Lewis酸例如为三溴化硼、三碘化硼、N,N-二乙基苯胺络合三碘化硼、三溴化硼-二甲基硫醚、9-溴-9-硼双环[3.3.0]壬烷、儿茶酚溴化硼(三氟化硼乙醚催化)中的至少一种,所述反应的溶剂例如为二氯甲烷、1,2-二氯乙烷。
本发明还提供式(I)所示的化合物在光刻中的应用,如在光刻胶中的应用。
本发明还提供一种光刻胶组合物,包括式(I)化合物。
根据本发明的实施方案,所述光刻胶组合物可以为正性光刻胶组合物或负性光刻胶组合物。
在本发明的一个实施方式中,所述光刻胶组合物为正性光刻胶组合物a,包括(I-a)化合物,所述(I-a)化合物为在式(I)所示的化合物中,R
1、R
2、R
3、R
4至少有一个基团为无取代或任选被一个、两个或更多个R
a取代的下列基团:C
1-20烷氧基、C
1-20烷氧基-C(=O)O-、C
1-20烷氧基-C
1-20烷氧基、C
6-20芳基-C(=O)O-C
1-20烷氧基、C
1-20烷氧基-C(=O)O-C
1-20烷氧基-C
1-20烷氧基、C
6-20芳基-C(=O)O-C
1-20烷氧基-C
1-20烷氧基、C
3-20环烷基氧基-C(=O)O-、C
3-20环烷基氧基-C(=O)-C
1-20烷氧基、C
2-20烯基-C
1-20烷氧基-、3-20元杂环基-O-或3-20元杂环基-C
1-20烷氧基-,且R
1、R
2、R
3、R
4至多有一个基团为OH的式(I)化合物。
根据本发明的实施方案,所述正性光刻胶组合物a由(I-a)化合物、光刻胶溶剂、光致产酸剂组成。即该正性光刻胶组合物a为一种正性单分子光刻胶。
优选地,所述正性光刻胶组合物a,以质量分数计,含有0.1%~10%的(I-a)化 合物,0.01%~1%的光致产酸剂。
根据本发明的实施方案,所述正性光刻胶组合物a还可选择性地含有其他光刻胶、酸扩散抑制剂等。
优选地,所述正性光刻胶组合物a,以质量分数计,含有0%~5%的其他光刻胶,0%~0.1%的酸扩散抑制剂。
在本发明的一个实施方式中,所述光刻胶组合物为负性光刻胶组合物b,包括(I-b)化合物,所述(I-b)化合物为在式(I)所示的化合物中,R
1、R
2、R
3、R
4至少含有两个-OH的式(I)化合物。
根据本发明的实施方案,所述负性光刻胶组合物b由(I-b)化合物、光刻胶溶剂、光致产酸剂、交联剂组成。即该负性光刻胶组合物b为一种负性单分子光刻胶。
优选地,所述负性光刻胶组合物b,以质量分数计,含有0.1%~10%的(I-b)化合物,0.01%~1%的光致产酸剂,0.01%~5%的交联剂。
根据本发明的实施方案,所述负性光刻胶组合物b还可选择性地含有其他光刻胶、酸扩散抑制剂等。
优选地,所述负性光刻胶组合物b,含有0%~5%的其他光刻胶,0%~0.1%的酸扩散抑制剂。
在本发明的一个实施方式中,所述光刻胶组合物为负性光刻胶组合物c,包括(I-c)化合物,所述(I-c)化合物为在式(I)所示的化合物中,R
1、R
2、R
3、R
4中至少有一个基团为C
2-20烯基-C
1-20烷氧基、3-8元杂环基-O-、3-8元杂环基-C
1-8烷氧基的式(I)化合物。
根据本发明的实施方案,所述负性光刻胶组合物c由(I-c)化合物、光刻胶溶剂、光致产酸剂组成。即该负性光刻胶组合物c为另一种负性单分子光刻胶。
优选地,所述负性光刻胶组合物c,以质量分数计,含有0.1%~10%的(I-c)化合物,0.01%~1%的光致产酸剂。
根据本发明的实施方案,所述负性光刻胶组合物c还可选择性地含有光刻胶、酸扩散抑制剂、交联剂等。
优选地,所述负性光刻胶组合物c,以质量分数计,含有0%~5%的光刻胶,0%~0.1%的酸扩散抑制剂,0.01%~5%的交联剂。
根据本发明的实施方案,所述其他光刻胶可以是现有技术中已知的光刻胶,如专利文献201210156675.6、201210070713.6、201611105094.4、201911329042.9、201911167289.5、202010803879.9所公开的光刻胶。
根据本发明的实施方案,所述光致产酸剂可以为离子型或非离子型,如选自三苯基锍三氟甲磺酸盐、三苯基锍全氟丁基磺酸盐、二(4-叔丁基苯基)碘鎓对甲苯磺酸盐、N-羟基萘酰亚胺三氟甲磺酸盐、2-苯基-(4-苯基硫)苯基硫六氟锑酸盐、苄基(4-羟苯基)甲基硫鎓六氟锑酸盐、六氟锑酸盐混盐等中的至少一种。
根据本发明的实施方案,所述光刻胶溶剂可以选自丙二醇甲醚醋酸酯(PGMEA)、乳酸乙酯、乙二醇单甲醚、环己酮等中的至少一种。
根据本发明的实施方案,所述酸扩散抑制剂可以选自正辛胺、三正辛胺、N-甲基二正辛胺、叔辛胺等。
根据本发明的实施方案,所述交联剂可以选自四甲氧基甲基甘脲、双酚A型环氧丙基醚等中的至少一种。
根据本发明的实施方案,所述光刻胶组合物还可以包括其他添加剂,如增感剂、表面活性剂、染料、稳定剂、助溶剂等。
本发明又提供一种式(I)所示化合物或所述光刻胶组合物在365nm光刻、248nm光刻、193nm光刻、极紫外(EUV)光刻或电子束光刻(EBL)等光刻工艺中的应用。
本发明还提供一种光刻胶涂层,包括式(I)所示化合物。
本发明还提供所述光刻胶涂层的制备方法,包括将所述光刻胶组合物在基底上进行涂抹(如旋涂)得到。
优选地,所述涂抹方式是通过匀胶机在基底上进行旋涂。
优选地,所述基底可以为硅片、二氧化硅片、化合物半导体片。所述硅片优选为经过疏水处理后的硅片。
1.本发明将含硅的基团引入到光刻胶主体材料分子中,获得了具有高抗刻蚀性的光刻胶材料。
2.本发明通式(I)所示的化合物是立体不对称的无定形小分子化合物,化合物分子结构简洁,分子量可控,合成步骤简单,且其具有较高的热稳定性,烘烤中不析出,光刻中不易变性,具有较高的熔点和玻璃化转变温度(熔点均高于100℃),能够满足光刻技术要求,在高温烘烤中薄膜结构无变化。
3.本发明的光刻胶组合物可以制备得到均匀的薄膜,所述薄膜具有良好的分辨率、光敏性、粘附性,易于保存,且在制膜过程中,作为基体成分的分子玻璃不析出。本发明制备的负性光刻胶组合物具有较好的成膜性,较高的热稳定性,储存不易变性,且粘度低,使用过程中无需额外使用溶剂稀释。电子束曝光显影后,曝光图形具有较高的对比度,优异的分辨率,较好的灵敏度,能够达到25-30nm的光刻线宽。
图1为化合物(IB)的TGA曲线,当温度为300℃时,分解含量小于10%,可以看出化合物(1A)具有很高的热稳定性。
图2为化合物(IB)的电子束曝光60nm周期密集线条的SEM结果。
图3为化合物(IB-2)的电子束曝光60nm周期线条的SEM结果。
术语定义与说明
除非另有说明,本申请说明书和权利要求书中记载的基团和术语定义,包括 其作为实例的定义、示例性的定义、优选的定义、表格中记载的定义、实施例中具体化合物的定义等,可以彼此之间任意组合和结合。这样的组合和结合后的基团定义及化合物结构,应当被理解为本申请说明书和/或权利要求书记载的范围内。
除非另有说明,本说明书和权利要求书记载的数值范围相当于至少记载了其中每一个具体的整数数值。例如,数值范围“1-20”相当于记载了数值范围“1-20”中的每一个整数数值,即1、2、3、4、5、6、7、8、9、10、11、12、13、14、15、161、7、18、19、20。
术语“C
1-20烷基”应理解为表示具有1~20个碳原子的直链和支链烷基,优选“C
1-8烷基”。“C
1-8烷基”表示具有1、2、3、4、5、6、7、或8个碳原子的直链和支链烷基,“C
1-6烷基”表示具有1、2、3、4、5或6个碳原子的直链和支链烷基。所述烷基是例如甲基、乙基、丙基、丁基、戊基、己基、异丙基、异丁基、仲丁基、叔丁基、异戊基、2-甲基丁基、1-甲基丁基、1-乙基丙基、1,2-二甲基丙基、新戊基、1,1-二甲基丙基、4-甲基戊基、3-甲基戊基、2-甲基戊基、1-甲基戊基、2-乙基丁基、1-乙基丁基、3,3-二甲基丁基、2,2-二甲基丁基、1,1-二甲基丁基、2,3-二甲基丁基、1,3-二甲基丁基或1,2-二甲基丁基等或它们的异构体。
术语“C
3-20环烷基”应理解为表示饱和的一价单环、二环(如稠环、桥环、螺环)烃环或三环烷烃,其具有3~29个碳原子,优选“C
3-12环烷基”,更优选“C
3-8环烷基”。术语“C
3-12环烷基”应理解为表示饱和的一价单环、双环(如桥环、螺环)烃环或三环烷烃,其具有3、4、5、6、7、8、9、10、11或12个碳原子。所述C
3-12环烷基可以是单环烃基,如环丙基、环丁基、环戊基、环己基、环庚基、环辛基、环壬基或环癸基,或者是双环烃基如龙脑基、吲哚基、六氢吲哚基、四氢萘基、十氢萘基、二环[2.1.1]己基、二环[2.2.1]庚基、二环[2.2.1]庚烯基、6,6-二甲基二环[3.1.1]庚基、2,6,6-三甲基二环[3.1.1]庚基、二环[2.2.2]辛基、2,7-二氮杂螺[3,5]壬烷基、2,6-二氮杂螺[3,4]辛烷基,或者是三环烃基如金刚烷基。
术语“C
2-20烯基”应理解为表示直连或支链的一价烃基,其包含一个或多个双键并且具有2~20个碳原子,优选“C
2-10烯基”。“C
2-10烯基”应理解为优选表示直连或支链的一价烃基,其包含一个或多个双键并且具有2、3、4、5、6、7、8、9或10个碳原子,更优选“C
2-8烯基”。“C
2-10烯基”应理解为优选表示直连或支链的一价烃基,其包含一个或多个双键并且具有2、3、4、5、6、7或8个碳原子,例如,具有2、3、4、5或6个碳原子(即,C
2-6烯基),具有2或3个碳原子(即,C
2-3烯基)。应理解,在所述烯基包含多于一个双键的情况下,所述双键可相互分离或者共轭。所述烯基是例如乙烯基、烯丙基、(E)-2-甲基乙烯基、(Z)-2-甲基乙烯基、(E)-丁-2-烯基、(Z)-丁-2-烯基、(E)-丁-1-烯基、(Z)-丁-1-烯基、戊-4-烯基、(E)-戊-3-烯基、(Z)-戊-3-烯基、(E)-戊-2-烯基、(Z)-戊-2-烯基、(E)-戊-1-烯基、(Z)-戊-1-烯基、己-5-烯基、(E)-己-4-烯基、(Z)-己-4-烯基、(E)-己-3-烯基、(Z)-己-3-烯基、(E)-己-2-烯基、(Z)-己-2-烯基、(E)-己-1-烯基、(Z)-己-1-烯基、异丙烯基、2-甲基丙-2-烯基、1-甲基丙-2-烯基、2-甲基丙-1-烯基、(E)-1-甲基丙-1-烯基、(Z)-1-甲基丙-1-烯基、3-甲基丁-3-烯基、2-甲基丁-3-烯基、1-甲基丁-3-烯基、3-甲基丁-2-烯基、(E)-2-甲基丁-2-烯基、(Z)-2-甲基丁-2-烯基、(E)-1-甲基丁-2-烯基、(Z)-1-甲基丁-2-烯基、(E)-3-甲基丁-1-烯基、(Z)-3-甲基丁-1-烯基、(E)-2-甲基丁-1-烯基、(Z)-2-甲基丁-1-烯基、(E)-1-甲基丁-1-烯基、(Z)-1-甲基丁-1-烯基、1,1-二甲基丙-2-烯基、1-乙基丙-1-烯基、1-丙基乙烯基、1-异丙基乙烯基。
术语“3-20元杂环基”是指饱和的或不饱和的非芳族的环或环系,例如,其是4-、5-、6-或7-元的单环、7-、8-、9-、10-、11-或12-元的二环(如稠环、桥环、螺环)或者10-、11-、12-、13-、14-或15-元的三环环系,并且含有至少一个,例如1、2、3、4、5个或更多个选自O、S和N的杂原子,其中N和S还可以任选被氧化成各种氧化状态,以形成氮氧化物、-S(O)-或-S(O)
2-的状态。优选地,所述杂环基可以选自“3-10元杂环基”。术语“3-10元杂环基”意指饱和的或不饱和的非芳族的环或环系,并且含有至少一个选自O、S和N的杂原子。所述杂环基可以通过所述碳 原子中的任一个或氮原子(如果存在的话)与分子的其余部分连接。所述杂环基可以包括稠合的或桥连的环以及螺环的环。特别地,所述杂环基可以包括但不限于:4元环,如氮杂环丁烷基、氧杂环丁烷基;5元环,如四氢呋喃基、二氧杂环戊烯基、吡咯烷基、咪唑烷基、吡唑烷基、吡咯啉基;或6元环,如四氢吡喃基、哌啶基、吗啉基、二噻烷基、硫代吗啉基、哌嗪基或三噻烷基;或7元环,如二氮杂环庚烷基。
术语“C
6-20芳基”应理解为优选表示具有6~20个碳原子的一价芳香性或部分芳香性的单环、二环(如稠环、桥环、螺环)或三环烃环,其可以是单芳族环或稠合在一起的多芳族环,优选“C
6-14芳基”。术语“C
6-14芳基”应理解为优选表示具有6、7、8、9、10、11、12、13或14个碳原子的一价芳香性或部分芳香性的单环、双环或三环烃环(“C
6-14芳基”),特别是具有6个碳原子的环(“C
6芳基”),例如苯基;或联苯基,或者是具有9个碳原子的环(“C
9芳基”),例如茚满基或茚基,或者是具有10个碳原子的环(“C
10芳基”),例如四氢化萘基、二氢萘基或萘基,或者是具有13个碳原子的环(“C
13芳基”),例如芴基,或者是具有14个碳原子的环(“C
14芳基”),例如蒽基。当所述C
6-20芳基被取代时,其可以为单取代或者多取代。并且,对其取代位点没有限制,例如可以为邻位、对位或间位取代。
术语“5-20元杂芳基”应理解为包括这样的一价单环、二环(如稠环、桥环、螺环)或三环芳族环系:其具有5~20个环原子且包含1-5个独立选自N、O和S的杂原子,例如“5-14元杂芳基”。术语“5-14元杂芳基”应理解为包括这样的一价单环、双环或三环芳族环系:其具有5、6、7、8、9、10、11、12、13或14个环原子,特别是5或6或9或10个碳原子,且其包含1-5个,优选1-3各独立选自N、O和S的杂原子并且,另外在每一种情况下可为苯并稠合的。“杂芳基”还指其中杂芳族环与一个或多个芳基、脂环族或杂环基环稠合的基团,其中所述连接的根基或点在杂芳族环上。
下文将结合具体实施例对本发明的技术方案做更进一步的详细说明。应当理解,下列实施例仅为示例性地说明和解释本发明,而不应被解释为对本发明保护范围的限制。凡基于本发明上述内容所实现的技术均涵盖在本发明旨在保护的范围内。
除非另有说明,以下实施例中使用的原料和试剂均为市售商品,或者可以通过已知方法制备。
实施例1:化合物P1的合成制备
称量5.44g(10mmol)的四溴双酚A,1.7g(25mmol)咪唑,加入100mL两口瓶中。反复抽排气3次,量取50mL DMF加入两口烧瓶中,搅拌溶解后缓慢加入6.9g(25mmol)的叔丁基二苯氯硅烷(TBDPSCl),室温下反应3h。反应结束后,用二氯甲烷将反应物稀释,依次用稀盐酸、去离子水洗涤三次。MgSO
4干燥4小时后,通过乙醇溶剂交换,真空60℃干燥8h得到化合物P1。
实施例2:化合物P2的合成制备
称量10.2g(10mmol)的化合物P1,6.84g(45mmol)的4-甲氧基苯硼酸,依次加入500mL的三口烧瓶中,加入150mL 1,4-二氧六环充分搅拌溶解。在搅拌 条件下加入40w.t.%碳酸钾溶液80mL,升温至90℃后加入1.138g四三苯基膦钯。在90℃下回流6h。反应结束后,用二氯甲烷将反应混合物稀释,然后用饱和食盐水洗涤三次,用MgSO
4干燥4h后以乙醇为不良溶剂析出化合物P2,60℃真空干燥8h后,得到化合物P2。
实施例3:化合物(IA)的合成制备
称量11.3g(10mmol)的化合物P2溶于100mL二氯甲烷中,并将溶液转移至恒压滴液漏斗中。量取100mL二氯甲烷加入500mL三口烧瓶中,在冰水浴条件下加入4.1mL(45mmol)BBr
3进行搅拌。控制反应温度为0℃条件下,将恒压滴液漏斗中的溶液缓慢加入三口烧瓶中,反应3h后,收集三口烧瓶中的反应液于恒压滴液漏斗中,量取200mL去离子水加入1000mL三口烧瓶中,控制反应温度为0℃,将恒压滴液漏斗中的反应液加入至三口烧瓶中,猝灭多余的BBr
3。反应结束后,用乙酸乙酯进行萃取,去离子水洗涤3次,经MgSO
4干燥4h后以正己烷作不良溶剂析出化合物(IA),60℃真空干燥8h后,得到化合物(IA)。MALDI-TOF(C
71H
68NaO
6Si
2)m/z:[M+Na]1095.44
实施例4:化合物(IB)的合成制备
称量2.15g(2mmol)的化合物(IA)、2.24g(40mmol)KOH,依次加入50mL两口烧瓶中,然后加入1.37g(10mmol)溴代环氧丙烷,再加入10mL的N-甲基吡咯烷酮,在65℃下反应4h。反应结束后,用二氯甲烷稀释反应混合物,然后用去离子水洗涤3次,加入无水MgSO
4干燥4h后进行硅胶柱分离(洗脱剂为四氢呋喃∶石油醚=2:1),收集产物旋干后经60℃真空干燥箱干燥8h得化合物(IB),1.244g,产率为48%。MALDI-TOF(C
83H
84NaO
10Si
2)m/z:1319.55。
1H NMR(300MHz,DMSO)δ7.10(s,28H),6.91(s,4H),6.63(d,J=8.4Hz,8H),4.23(d,J=11.4Hz,5H),3.73(dd,J=11.5,6.3Hz,5H),2.84(t,J=4.5Hz,5H),2.70(s,5H),1.62(s,6H),0.47(s,18H).
实施例5:化合物(IB-2)合成方法参考实施例1-4,通过改变叔丁基二苯基硅基为叔丁基二甲基硅基,制备得到化合物(IB-2),分子式如下:MALDI-TOF(C
83H
84NaO
10Si
2)m/z:1048.497。
1H NMR(300MHz,DMSO)δ7.42(d,J=8.5Hz,8H),7.09(s,4H),6.95(d,J=8.6Hz,8H),4.34(dd,J=11.4,2.1Hz,4H),3.82(dd,J=11.4,6.6Hz,4H),2.84(t,J=4.6Hz,4H),2.71(dd,J=5.0,2.6Hz,4H),1.74(s,6H),1.35(s,4H),0.66(s,18H),-0.78(s,12H).
实施例6:含化合物(IB)负性光刻胶组合物的制备
称量化合物(IB)100mg,光致产酸剂苄基(4-羟苯基)甲基硫鎓六氟锑酸盐7.5mg,添加剂7.5mg。量取光刻胶溶剂丙二醇甲醚醋酸酯(PGMEA)5mL,配制的光刻胶溶液浓度为20mg/mL。超声处理30min后用0.20μm的聚四氟乙烯薄膜过滤三次,制备成负性光刻胶组合物。
实施例7:含化合物(IB-2)负性光刻胶组合物的制备
基本参照实施例6,将化合物(IB-2)替换为化合物(IB)。制备得到30mg/mL的负性光刻胶组合物。
实施例8含化合物(IB)的负性光刻胶组合物的光刻性能
选取未经过处理的空白硅片,氮气枪吹净表面的灰尘,将实施例6制备的负性光刻胶组合物旋涂在硅片上,设置旋涂参数为2800rpm/90s,前烘参数为80℃/180s。采用光学椭偏仪测量膜的厚度,为43nm。采用加速电压为100kV的电子束进行曝光,后烘参数为90℃/120s。再用甲基异丁基甲酮:异丙醇=5:1的显影液显影60s,异丙醇润洗60s。显影后使用日立8230扫描电子显微镜采集SEM图,具体的光刻结果如图2所示。由图2可知,光刻胶组合物可以实现30nm的光刻条纹,并且具有较高的灵敏度(166μC/cm
2)以及较高的对比度。
实施例9含化合物(IB-2)的负性光刻胶组合物的光刻性能
选取未经过处理的空白硅片,氮气枪吹净表面的灰尘,将实施例7制备的负性光刻胶组合物旋涂在硅片上,设置旋涂参数为4500rpm/90s,前烘参数为80℃/180s。采用光学椭偏仪测量膜厚为41.2nm。采用加速电压为100kV的电子束进行曝光,后烘参数为90℃/120s。用甲基异丁基甲酮显影液显影60s,异丙醇润洗60s。显影后使用日立8230扫描电子显微镜采集SEM图,具体的光刻结果如图3所示。由图3可知,光刻胶组合物可以实现30nm的光刻条纹,并且具有较高的灵敏度(320μC/cm
2)以及较高的对比度。
以上对本发明技术方案的实施方式进行了示例性的说明。应当理解,本发明的保护范围不拘囿于上述实施方式。凡在本发明的精神和原则之内,本领域技术人员所做的任何修改、等同替换、改进等,均应包含在本申请权利要求书的保护范围之内。
Claims (10)
- 一类式(I)所示的化合物:其中,每个R 1、R 2、R 3相同或不同,彼此独立的选自H、OH、无取代或任选被一个、两个或更多个R a取代的下列基团:C 1-20烷基、C 1-20烷氧基、C 1-20烷氧基-C(=O)O-、C 1-20烷氧基-C 1-20烷氧基-、C 6-20芳基-C(=O)O-C 1-20烷氧基-、C 1-20烷氧基-C(=O)O-C 1-20烷氧基-C 1-20烷氧基、C 6-20芳基-C(=O)O-C 1-20烷氧基-C 1-20烷氧基-、C 3-20环烷基氧基-C(=O)O-、C 3-20环烷基氧基-C(=O)-C 1-20烷氧基-、C 2-20烯基-C 1-20烷氧基-、3-20元杂环基-O-、3-20元杂环基-C 1-20烷氧基-;且R 1、R 2、R 3不同时选自H、OH或C 1-20烷基中的同一基团;每个R 4相同或不同,彼此独立的选自OH、无取代或任选被一个、两个或更多个R b取代的下列基团:C 1-20烷基、C 1-20烷氧基、C 1-20烷氧基-C(=O)O-、C 1-20烷氧基-C 1-20烷氧基-、C 6-20芳基-C(=O)O-C 1-20烷氧基-、C 1-20烷氧基-C(=O)O-C 1-20烷氧基-C 1-20烷氧基-、C 6-20芳基-C(=O)O-C 1-20烷氧基-C 1-20烷氧基-、C 3-20环烷基氧基-C(=O)O-、C 3-20环烷基氧基-C(=O)-C 1-20烷氧基-、C 2-20烯基-C 1-20烷氧基-、3-20元杂环基-O-、3-20元杂环基-C 1-20烷氧基-、-OSi(R b1) 3;且R 4中至少有一个为-OSi(R b1) 3;每个R a、R b相同或不同,彼此独立地选自氧代(=O)、C 1-20烷基、C 1-20烷氧基、C 3-20环烷基、C 2-20烯基、3-20元杂环基、C 6-20芳基;每个R b1相同或不同,彼此独立地选自C 1-20烷基、C 3-20环烷基、C 2-20烯基、3-20 元杂环基、C 6-20芳基。
- 根据权利要求1所述的化合物,其特征在于,R 1、R 2、R 3中至少有一个基团不为H,或者至少有一个基团不为OH,或者至少有一个基团不为C 1-20烷基。优选地,每个R 1、R 2、R 3相同或不同,彼此独立的选自H、OH、C 1-10烷基、C 1-10烷氧基、C 1-10烷氧基-C(=O)O-、C 1-10烷氧基-C 1-10烷氧基-、C 6-20芳基-C(=O)O-C 1-10烷氧基-、C 1-10烷氧基-C(=O)O-C 1-10烷氧基-C 1-10烷氧基、C 6-20芳基-C(=O)O-C 1-10烷氧基-C 1-10烷氧基-、C 3-12环烷基氧基-C(=O)O-、C 3-12环烷基氧基-C(=O)-C 1-10烷氧基-、C 2-20烯基-C 1-10烷氧基-、3-12元杂环基-O-、3-12元杂环基-C 1-10烷氧基-;优选地,每个R 1、R 2、R 3相同或不同,彼此独立的选自H、OH、C 1-8烷氧基、C 1-8烷氧基-C(=O)O-、C 1-8烷氧基-C 1-8烷氧基-、C 6-14芳基-C(=O)O-C 1-8烷氧基-、C 1-8烷氧基-C(=O)O-C 1-8烷氧基-C 1-8烷氧基、C 6-14芳基-C(=O)O-C 1-8烷氧基-C 1-8烷氧基-、C 3-8环烷基氧基-C(=O)O-、C 3-8环烷基氧基-C(=O)-C 1-8烷氧基-、C 2-8烯基-C 1-8烷氧基-、3-8元杂环基-O-、3-8元杂环基-C 1-8烷氧基-;
- 根据权利要求1或2所述的化合物,其特征在于,每个R 4相同或不同,彼此独立地选自OH、C 1-20烷基、C 1-20烷氧基、(C 1-20烷基) 3SiO-、(芳基) 2(C 1-20烷基)SiO-、(芳基)(C 1-20烷基) 2SiO-、C 1-20烷氧基-C(=O)O-、C 1-20烷氧基-C 1-20烷氧基、C 6-20芳 基-C(=O)O-C 1-20烷氧基、C 1-20烷氧基-C(=O)O-C 1-20烷氧基-C 1-20烷氧基、C 6-20芳基-C(=O)O-C 1-20烷氧基-C 1-20烷氧基、C 3-20环烷基氧基-C(=O)O-、C 3-20环烷基氧基-C(=O)-C 1-20烷氧基、C 2-20烯基-C 1-20烷氧基、3-20元杂环基-O-、3-20元杂环基-C 1-20烷氧基;且R 4中至少有一个为(C 1-20烷基) 3SiO-、(芳基) 2(C 1-20烷基)SiO-、(芳基)(C 1-20烷基) 2SiO-;优选地,每个R 4相同或不同,彼此独立地选自OH、C 1-8烷氧基、C 1-8烷氧基-C(=O)O-、C 1-8烷氧基-C 1-8烷氧基、C 6-14芳基-C(=O)O-C 1-8烷氧基、C 1-8烷氧基-C(=O)O-C 1-8烷氧基-C 1-8烷氧基、C 3-8环烷基氧基-C(=O)O-、C 3-8环烷基氧基-C(=O)-C 1-8烷氧基、C 2-8烯基-C 1-8烷氧基、3-8元杂环基-O-、3-8元杂环基-C 1-8烷氧基;优选地,R 1、R 2、R 3、R 4中,所述杂环基为含氧杂环基,例如为3-8元氧杂环烷基,例如氧杂环丙基、氧杂环丁基、氧杂环戊基、氧杂环己基。
- 权利要求1-4任一项所述化合物的制备方法,包括以下步骤:(1)化合物(II)与化合物R 4X或(R 4) 2NH反应得到化合物(III);(2)化合物(III)与化合物(IV)反应生成式(I)所示化合物;
- 权利要求1-4任一项所述的化合物在光刻中的应用,如在光刻胶中的应用。
- 一种光刻胶组合物,包括权利要求1-4任一项所述的化合物;优选地,所述光刻胶组合物可以为正性光刻胶组合物或负性光刻胶组合物;优选地,所述光刻胶组合物选自如下所述的正性光刻胶组合物a、负性光刻胶组合物b或负性光刻胶组合物c:正性光刻胶组合物a:所述正性光刻胶组合物a包括(I-a)化合物;所述(I-a)化合物为当权利要求1-4任一项所述的式(I)所示的化合物中R 1、R 2、R 3、R 4至少有一个基团为无取代或任选被一个、两个或更多个R a取代的下列基团:C 1-20烷氧基、C 1-20烷氧基-C(=O)O-、C 1-20烷氧基-C 1-20烷氧基、C 6-20芳基-C(=O)O-C 1-20烷氧基、C 1-20烷氧基-C(=O)O-C 1-20烷氧基-C 1-20烷氧基、C 6-20芳基-C(=O)O-C 1-20烷氧基-C 1-20烷氧基、C 3-20环烷基氧基-C(=O)O-、C 3-20环烷基氧基-C(=O)-C 1-20烷氧基、C 2-20烯基-C 1-20烷氧基-、3-20元 杂环基-O-或3-20元杂环基-C 1-20烷氧基-,且R 1、R 2、R 3、R 4至多有一个基团为OH的式(I)化合物;优选地,所述正性光刻胶组合物a由(I-a)化合物、光刻胶溶剂、光致产酸剂组成。优选地,所述正性光刻胶组合物a,以质量分数计,含有0.1%~10%的(I-a)化合物,0.01%~1%的光致产酸剂;负性光刻胶组合物b;所述负性光刻胶组合物b包括(I-b)化合物;所述(I-b)化合物为当权利要求1-4任一项所述的式(I)所示的化合物中R 1、R 2、R 3、R 4至少含有两个-OH的式(I)化合物;优选地,所述负性光刻胶组合物b由(I-b)化合物、光刻胶溶剂、光致产酸剂、交联剂组成;优选地,所述负性光刻胶组合物b,以质量分数计,含有0.1%~10%的(I-b)化合物,0.01%~1%的光致产酸剂,0.01%~5%的交联剂;负性光刻胶组合物c:所述负性光刻胶组合物c包括(I-c)化合物;所述(I-c)化合物为当权利要求1-4任一项所述的式(I)所示的化合物中R 1、R 2、R 3、R 4中至少有一个基团为C 2-20烯基-C 1-20烷氧基、3-8元杂环基-O-、3-8元杂环基-C 1-8烷氧基的式(I)化合物;优选地,所述负性光刻胶组合物c由(I-c)化合物、光刻胶溶剂、光致产酸剂组成;优选地,所述负性光刻胶组合物c,以质量分数计,含有0.1%~10%的(I-c)化合物,0.01%~1%的光致产酸剂。
- 权利要求7所述光刻胶组合物在365nm光刻、248nm光刻、193nm光刻、 极紫外(EUV)光刻或电子束光刻(EBL)工艺中的应用。
- 一种光刻胶涂层,包括权利要求7所述的光刻胶组合物。
- 权利要求9所述光刻胶涂层的制备方法,包括将所述光刻胶组合物在基底上进行涂抹得到。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/128209 WO2024087158A1 (zh) | 2022-10-28 | 2022-10-28 | 含硅高抗刻蚀分子玻璃光刻胶化合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/128209 WO2024087158A1 (zh) | 2022-10-28 | 2022-10-28 | 含硅高抗刻蚀分子玻璃光刻胶化合物及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024087158A1 true WO2024087158A1 (zh) | 2024-05-02 |
Family
ID=90829656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/128209 WO2024087158A1 (zh) | 2022-10-28 | 2022-10-28 | 含硅高抗刻蚀分子玻璃光刻胶化合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024087158A1 (zh) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6190837B1 (en) * | 1996-06-27 | 2001-02-20 | Hyundai Electronics Industries Co., Ltd. | Method for forming photoresist film pattern |
CN103304385A (zh) * | 2012-03-16 | 2013-09-18 | 中国科学院化学研究所 | 含双酚a骨架结构的分子玻璃光刻胶及其制备方法和应用 |
CN104412162A (zh) * | 2012-07-04 | 2015-03-11 | 株式会社钟化 | 正型感光性组合物、薄膜晶体管及化合物 |
CN104914672A (zh) * | 2015-06-11 | 2015-09-16 | 中国科学院化学研究所 | 基于含多羟基结构分子玻璃的底部抗反射涂料组合物及其在光刻中的应用 |
CN108084028A (zh) * | 2016-11-23 | 2018-05-29 | 中国科学院化学研究所 | 含双酚a骨架结构的分子玻璃光刻胶的制备方法 |
CN108147983A (zh) * | 2016-12-05 | 2018-06-12 | 中国科学院化学研究所 | 一类硫鎓盐键合苯多酚型分子玻璃光刻胶及其制备方法和应用 |
CN110032040A (zh) * | 2018-01-12 | 2019-07-19 | 中国科学院化学研究所 | 化学放大胶组合物及其在紫外光刻的应用 |
CN112142769A (zh) * | 2019-06-27 | 2020-12-29 | 中国科学院理化技术研究所 | 含硅多苯基单分子树脂及其光刻胶组合物 |
WO2022032945A1 (zh) * | 2020-08-11 | 2022-02-17 | 中国科学院化学研究所 | 一种双酚a衍生物及其制备方法和在光刻中的应用 |
-
2022
- 2022-10-28 WO PCT/CN2022/128209 patent/WO2024087158A1/zh unknown
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6190837B1 (en) * | 1996-06-27 | 2001-02-20 | Hyundai Electronics Industries Co., Ltd. | Method for forming photoresist film pattern |
CN103304385A (zh) * | 2012-03-16 | 2013-09-18 | 中国科学院化学研究所 | 含双酚a骨架结构的分子玻璃光刻胶及其制备方法和应用 |
CN104412162A (zh) * | 2012-07-04 | 2015-03-11 | 株式会社钟化 | 正型感光性组合物、薄膜晶体管及化合物 |
CN104914672A (zh) * | 2015-06-11 | 2015-09-16 | 中国科学院化学研究所 | 基于含多羟基结构分子玻璃的底部抗反射涂料组合物及其在光刻中的应用 |
CN108084028A (zh) * | 2016-11-23 | 2018-05-29 | 中国科学院化学研究所 | 含双酚a骨架结构的分子玻璃光刻胶的制备方法 |
CN108147983A (zh) * | 2016-12-05 | 2018-06-12 | 中国科学院化学研究所 | 一类硫鎓盐键合苯多酚型分子玻璃光刻胶及其制备方法和应用 |
CN110032040A (zh) * | 2018-01-12 | 2019-07-19 | 中国科学院化学研究所 | 化学放大胶组合物及其在紫外光刻的应用 |
CN112142769A (zh) * | 2019-06-27 | 2020-12-29 | 中国科学院理化技术研究所 | 含硅多苯基单分子树脂及其光刻胶组合物 |
WO2020259126A1 (zh) * | 2019-06-27 | 2020-12-30 | 中国科学院理化技术研究所 | 含硅多苯基单分子树脂及其光刻胶组合物 |
WO2022032945A1 (zh) * | 2020-08-11 | 2022-02-17 | 中国科学院化学研究所 | 一种双酚a衍生物及其制备方法和在光刻中的应用 |
CN114075155A (zh) * | 2020-08-11 | 2022-02-22 | 中国科学院化学研究所 | 一种双酚a衍生物及其制备方法和在光刻中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104557552B (zh) | 一种星形四苯基乙烯衍生物分子玻璃、正性光刻胶、正性光刻胶涂层及其应用 | |
TWI534531B (zh) | 光阻組成物,光阻圖型之形成方法,高分子化合物 | |
TW200905394A (en) | Negative resist composition and pattern forming method using the same | |
TW201013333A (en) | Resist processing method | |
TW200910012A (en) | Resist composition for electron beam, X-ray, or EUV, and pattern-forming method using the same | |
JP7079647B2 (ja) | 組成物及びそれを用いたデバイスの製造方法 | |
TW201327056A (zh) | 矽化合物、縮合物及使用其之光阻組合物與使用其之圖案形成方法 | |
JP3907197B2 (ja) | フォトリソグラフィ用のチオフェン含有光酸発生剤 | |
TW202003460A (zh) | 鋶鹽、光酸產生劑、能量線硬化性組成物、硬化體、化學增幅型正型光阻組成物、抗蝕劑圖案之製作方法及化學增幅型負型光阻組成物 | |
JP6044283B2 (ja) | フラーレンc60誘導体、並びに極紫外線光又は電子ビーム露光用レジスト組成物 | |
WO2024087158A1 (zh) | 含硅高抗刻蚀分子玻璃光刻胶化合物及其制备方法和应用 | |
WO2020259126A1 (zh) | 含硅多苯基单分子树脂及其光刻胶组合物 | |
TW201116509A (en) | Cyclic compound, fabricating method thereof, radiation-sensitive composition, resist patern and formation method thereof | |
TW202120475A (zh) | 鋶鹽、酸產生劑、抗蝕劑組成物和裝置的製造方法 | |
WO2020233550A1 (zh) | 基于硫鎓盐的单分子树脂产酸剂及其光刻胶组合物 | |
CN117946151A (zh) | 含硅高抗刻蚀分子玻璃光刻胶化合物及其制备方法和应用 | |
TW200535565A (en) | Nitrogen-containing organic compound, resist composition and patterning process | |
KR102148772B1 (ko) | 신규한 중합체, 이를 포함하는 하층막 형성용 조성물 및 이를 이용한 방법 | |
CN111978224B (zh) | 含硫单分子树脂及其光刻胶组合物 | |
WO2014113914A1 (zh) | 螺芴衍生物分子玻璃及其制备方法和光刻中的应用 | |
CN116162186A (zh) | 基于聚苯乙烯类硫鎓盐的产酸剂及其光刻胶组合物 | |
JP2014201555A (ja) | スルホニウム塩、光酸発生剤、硬化性組成物およびレジスト組成物 | |
TW202206410A (zh) | 非離子系光酸產生劑、及光微影用樹脂組成物 | |
US20240174656A1 (en) | Fused ring aromatic hydrocarbon derivative, preparation method therefor, and use thereof in lithography | |
TW200934755A (en) | Novel sulfonate and radiation-sensitive resin composition |